Metraipolis › archive › dc_10351ffa415d

Day 8 monocyte and lymphocyte counts as a novel and early predictor for discontinuation in gynecologic cancer patients receiving paclitaxel and carboplatin… — Europe PMC PMID:41639876

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41639876
DOI
10.1186/s40780-[numero omesso]-5
License (as archived)
solo-consultazione
Archived
2026-11-06T03:23:46.726Z
SHA-256 of the archived text
c5f590e79fd2d9919616f094cf9586605c9f7b7c3aff7bce59ebc11fa1c200e9
Stable URL of this page
https://metraipolis.com/documento/dc_10351ffa415d

How to cite

Day 8 monocyte and lymphocyte counts as a novel and early predictor for discontinuation in gynecologic cancer patients receiving paclitaxel and carboplatin… — Europe PMC PMID:41639876 — Europe PMC (en), https://europepmc.org/article/MED/41639876 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_10351ffa415d (Metraipolis archive dc_10351ffa415d, sha256 c5f590e79fd2d9919616f094cf9586605c9f7b7c3aff7bce59ebc11fa1c200e9)
BibTeX
@misc{dc10351ffa415d,
  title = {Day 8 monocyte and lymphocyte counts as a novel and early predictor for discontinuation in gynecologic cancer patients receiving paclitaxel and carboplatin… — Europe PMC PMID:41639876},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41639876},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_10351ffa415d; sha256 c5f590e79fd2d9919616f094cf9586605c9f7b7c3aff7bce59ebc11fa1c200e9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41639876. Agents can read the archived copy with the MCP tool read_document.